SNTB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.762200E-01
Normal-vs-Stage2
6.950600E-01
Normal-vs-Stage3
3.286500E-02
Normal-vs-Stage4
7.102000E-01
Stage1-vs-Stage2
5.030400E-01
Stage1-vs-Stage3
3.588800E-01
Stage1-vs-Stage4
2.265400E-01
Stage2-vs-Stage3
1.610040E-01
Stage2-vs-Stage4
3.401200E-01
Stage3-vs-Stage4
6.564100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.922200E-01
Normal-vs-AfricanAmerican
8.854800E-01
Normal-vs-Asian
2.583600E-01
Caucasian-vs-AfricanAmerican
6.053400E-01
Caucasian-vs-Asian
3.449600E-01
AfricanAmerican-vs-Asian
2.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.309600E-01
Normal-vs-Female
6.020800E-01
Male-vs-Female
8.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.087600E-01
Normal-vs-Age(41-60Yrs)
9.727800E-01
Normal-vs-Age(61-80Yrs)
4.821400E-01
Normal-vs-Age(81-100Yrs)
2.817600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.687000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.243800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.962200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.382000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.178500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.939200E-01
Normal-vs-Daily Drinker
2.677400E-01
Normal-vs-Weekly Drinker
6.277800E-01
Normal-vs-Occasional Drinker
6.030000E-01
Normal-vs-Social Drinker
9.202600E-01
Non Drinker-vs-Daily Drinker
5.279800E-01
Non Drinker-vs-Weekly Drinker
5.122400E-01
Non Drinker-vs-Occasional Drinker
5.373600E-01
Non Drinker-vs-Social Drinker
2.703600E-01
Daily Drinker-vs-Weekly Drinker
2.601000E-01
Daily Drinker-vs-Occasional Drinker
2.627400E-01
Daily Drinker-vs-Social Drinker
1.529840E-01
Weekly Drinker-vs-Occasional Drinker
9.416800E-01
Weekly Drinker-vs-Social Drinker
6.656200E-01
Occasional Drinker-vs-Social Drinker
5.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.413600E-01
Normal-vs-Grade 2
1.019560E-01
Normal-vs-Grade 3
9.970100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.300600E-03
Grade 1-vs-Grade 3
4.202400E-03
Grade 1-vs-Grade 4
5.413600E-01
Grade 2-vs-Grade 3
5.771400E-01
Grade 2-vs-Grade 4
1.019560E-01
Grade 3-vs-Grade 4
9.970100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.114400E-01
Normal-vs-NonDiabetic
4.959600E-01
Diabetic-vs-NonDiabetic
9.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.818000E-01
Normal-vs-NoPancreatitis
5.459800E-01
Pancreatitis-vs-NoPancreatitis
7.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.738800E-01
Normal-vs-N1
7.130600E-01
N0-vs-N1
1.904970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.835200E-01
Normal-vs-TP53-NonMutant
4.812800E-01
TP53-Mutant-vs-TP53-NonMutant
4.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
